Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-300
Closed -$67.4K 428
2024
Q1
$67.4K Buy
+300
New +$67.7K 0.02% 279
2021
Q1
Sell
-11,500
Closed -$2.18M 416
2020
Q4
$2.18M Sell
11,500
-5,100
-31% -$952K 0.37% 95
2020
Q3
$2.92M Sell
16,600
-12,600
-43% -$2.01M 0.58% 55
2020
Q2
$4.48M Sell
29,200
-21,800
-43% -$3.32M 0.87% 33
2020
Q1
$7.14M Buy
+51,000
New +$7.63M 1.55% 17
2016
Q2
Sell
-700
Closed -$50K 316
2016
Q1
$50K Sell
700
-16,300
-96% -$1.1M 0.01% 132
2015
Q4
$1.28M Buy
+17,000
New +$1.23M 0.29% 79

Other funds holding STE

Denali Advisors's STE Position: Q2 2024 in Review

Denali Advisors sold out of Steris (STE) in Q2 2024, closing a stake of 300 shares — an estimated $67.4K sold.

Denali Advisors first reported a position in STE in Q4 2015 and held it in 7 quarters. The position peaked at $7.14M in Q1 2020. 747 funds tracked by Wall St. Rank hold STE as of Q2 2024.

  • Denali Advisors reported no remaining Steris position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 300 Steris shares in Q2 2024, an estimated $67.4K.
  • Denali Advisors first reported a position in Steris in Q4 2015 and held it in 7 quarters.
  • Denali Advisors's Steris position peaked at $7.14M in Q1 2020.
  • 747 funds tracked by Wall St. Rank held Steris as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.